Meeting in Athens, Greece, Thursday-Friday April 28 – 29, 2022
THURSDAY April 28th
12:00 LUNCH
13:00 Welcome and Introduction; Lutz Frölich, Frank Jessen, Nick Scarmeas
13:10 Host lectures on special topics Moderator: Frank Jessen
Junior Researchers Lectures
- Frailty in a community geriatric population: cognitive and other aspects. [10 min + 5 min discussion]
Eva Ntanasi, PhD, Neuropsychologist, Aiginition Hospital Cognitive Disorders Clinic - Cognitive dysfunction in Parkinsonian disorders including prodromal Parkinson’s disease [20 min + 5 min discussion]
Senior Researcher Lecture
- Blood based biomarkers: an update [30 min + 10 min discussion]
Oskar Hanson, MD, Clinical Memory Research Unit, Lund University, Lund, Sweden, Memory Clinic, Skåne University Hospital, Malmö, Sweden
14:30 EADC Symposium on Life-style factors and Cognition, Moderator: Nick Scarmeas
- Sleep and Cognitive dysfunction: biological and clinical aspects [15 min + 10 min discussion]
Elissaios Karageorgiou, MD, Global Brain Health Institute fellow, Neurological Institute of Athens. - Cognitive Reserve related lifestyle aspects and cognition [15 min + 10 min discussion]
Robert Perneczky: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig‐Maximilians‐Universität München, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany; Ageing Epidemiology (AGE) Research Unit, School of Public Health, Imperial College, London, UK
15:20 COFFEE break, Moderator: Lutz Frölich
15.50 EADC Presentation
- ARIA in Alzheimer’s disease and under treatment with amyloid antibodies [15 min + 10 min discussion]
Fabrizio Piazza, MD, CAA and AD Translational Research and Biomarkers Lab, School of Medicine, University of Milano-Bicocca
16:15 Roche sponsored Scientific Session – Update on Gantenerumab Clinical Program – Skyline Clinical Trial
- Introduction [5 min] – Antoine Chevrette – Roche GMCL
- From Scarlet to Graduate and beyond – Update on gantenerumab in early AD [15 min] – Dr Timo Grimmer – Germany
- The Skyline study – Gantenerumab in participants at-risk of or at the earliest stage of AD [15 min] – Dr Pierre Jean Ousset – France Q&A
17:00 Closing day
(EADC Executive Committee meeting 17:00 – 18:00)
19:30 DINNER
FRIDAY April 29th
08:30 COFFEE
09:00 EADC related completed or almost completed projects (10 min each + 3min discussion)
- Introduction on intersocietal efforts to harmonise patient assessment Giovanni Frisoni
- European intersocietal consensus on biomarker-based diagnosis of MCI Flavio Nobili
- Real world outcome measures in Alzheimer Pieter Jelle Visser
- EAN Guideline on management of dementia Kristian Steen Frederiksen
- Harmonization of EADC neuropsychological battery Marina Boccardi
- EADB Augustin Ruiz Laza
10:20 Updates: EADC related ongoing/upcoming projects (10 min each)
- AmyPad Pieter Jelle Visser
- RADAR-AD Casper de Boer
- EPND Pieter Jelle Visser
- PMI-AD Milica Kramberger
- ADDITION Milica Kramberger
- TIMING Rune Nielsen
11:30 COFFEE break
12:00 Upcoming calls
New IHI (previous IMI) call – JPND and other calls Pieter Jelle Visser
12:10 EADC – Pharma relations Frank Jessen
Open Discussion
12:40 Other EADC issues Lutz Frölich
Membership, bank account, change of leadership
12:45 Next meetings, Summary & Closing Nick Scarmeas, Lutz Frölich & Frank Jessen
13:00 LUNCH
